Albensi BC

References (2)

Title : Loss of Cholinergic Receptor Muscarinic 1 (CHRM1) Protein in the Hippocampus and Temporal Cortex of a Subset of Individuals with Alzheimer's Disease, Parkinson's Disease, or Frontotemporal Dementia: Implications for Patient Survival - Sabbir_2022_J.Alzheimers.Dis__
Author(s) : Sabbir MG , Speth RC , Albensi BC
Ref : J Alzheimers Dis , : , 2022
Abstract : Sabbir_2022_J.Alzheimers.Dis__
ESTHER : Sabbir_2022_J.Alzheimers.Dis__
PubMedSearch : Sabbir_2022_J.Alzheimers.Dis__
PubMedID: 36155524

Title : A review of clinical treatment considerations of donepezil in severe Alzheimer's disease - Adlimoghaddam_2018_CNS.Neurosci.Ther_24_876
Author(s) : Adlimoghaddam A , Neuendorff M , Roy B , Albensi BC
Ref : CNS Neurosci Ther , 24 :876 , 2018
Abstract : Adlimoghaddam_2018_CNS.Neurosci.Ther_24_876
ESTHER : Adlimoghaddam_2018_CNS.Neurosci.Ther_24_876
PubMedSearch : Adlimoghaddam_2018_CNS.Neurosci.Ther_24_876
PubMedID: 30058285